PCM
RMD icon

Penserra Capital Management’s ResMed RMD Stock Holding History

Penserra Capital Management’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2K Hold
12
– – ﹤0.01% 1054
2026
Q1 		$2K Hold
12
– – ﹤0.01% 1017
2025
Q4 		$2K Hold
12
– – ﹤0.01% 991
2025
Q3 		$3K Sell
12
-780
-98% -$213K ﹤0.01% 929
2025
Q2 		$204K Buy
792
+780
+6,500% +$186K ﹤0.01% 653
2025
Q1 		$2K Sell
12
-372
-97% -$86.8K ﹤0.01% 989
2024
Q4 		$87K Buy
384
+372
+3,100% +$89.6K ﹤0.01% 876
2024
Q3 		$2K Hold
12
– – ﹤0.01% 1031
2024
Q2 		$2K Hold
12
– – ﹤0.01% 1177
2024
Q1 		$2K Sell
12
-669
-98% -$123K ﹤0.01% 1157
2023
Q4 		$117K Sell
681
-142
-17% -$21.8K ﹤0.01% 876
2023
Q3 		$120K Sell
823
-131
-14% -$23.7K ﹤0.01% 856
2023
Q2 		$207K Buy
954
+946
+11,825% +$211K ﹤0.01% 780
2023
Q1 		$1K Hold
8
– – ﹤0.01% 1073
2022
Q4 		$1K Buy
+8
New +$1.76K ﹤0.01% 1114
2020
Q4 		– Sell
-468
Closed -$80K – 1118
2020
Q3 		$80K Sell
468
-34,430
-99% -$6.36M ﹤0.01% 540
2020
Q2 		$6.7M Buy
34,898
+34,283
+5,574% +$5.61M 0.35% 97
2020
Q1 		$100K Sell
615
-3,629
-86% -$578K 0.01% 575
2019
Q4 		$692K Buy
4,244
+3,672
+642% +$529K 0.04% 319
2019
Q3 		$77K Buy
572
+173
+43% +$22.7K 0.01% 594
2019
Q2 		$48K Buy
399
+33
+9% +$3.65K ﹤0.01% 592
2019
Q1 		$38K Sell
366
-14,563
-98% -$1.5M ﹤0.01% 574
2018
Q4 		$1.7M Buy
+14,929
New +$1.6M 0.17% 102

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Penserra Capital Management's RMD Position: Q2 2026 in Review

Penserra Capital Management held its ResMed (RMD) position steady in Q2 2026 at 12 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #1054.

Penserra Capital Management first reported a position in RMD in Q4 2018 and has held it in 23 quarters since. The position peaked at $6.7M in Q2 2020. 891 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Penserra Capital Management held 12 shares of ResMed worth $2K as of Q2 2026.
  • Penserra Capital Management left its ResMed share count unchanged in Q2 2026.
  • ResMed made up ﹤0.01% of Penserra Capital Management's portfolio in Q2 2026, its #1054 holding.
  • Penserra Capital Management first reported a position in ResMed in Q4 2018 and has held it in 23 quarters since.
  • Penserra Capital Management's ResMed position peaked at $6.7M in Q2 2020.
  • 891 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Penserra Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.